
Opinion|Videos|May 28, 2024
Hepatic Encephalopathy: Critical Insights and Closing Thoughts
In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, ASH Experts Review Newly Approved Therapies in Hemophilia
2
Pharmacist Strategies for Managing Comorbid Depression and Diabetes
3
Pharmacy Deserts: A Crisis Health Care Providers Can Help Solve with Technology and Teamwork
4
How a New Generation of CAR T-Cell Therapies Could Reduce the Risk of Rejection
5


















































































































































































































